Related Experiment Videos

Defining the optimal therapy for rectal cancer

Journal of the National Cancer Institute

|March 4, 2000

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis.

ESMO open·2025

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

Journal of surgical oncology·2007

A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.

British journal of cancer·2005

See all related articles